HA
RMD icon

Halsey Associates’s ResMed RMD Stock Holding History

Halsey Associates’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$22.4M Buy
165,966
+5,413
+3% +$709K 3.56% 7
2019
Q2 		$19.6M Sell
160,553
-8,609
-5% -$954K 3.5% 7
2019
Q1 		$17.6M Buy
169,162
+2,237
+1% +$231K 2.89% 11
2018
Q4 		$19M Buy
166,925
+6,713
+4% +$719K 3.58% 8
2018
Q3 		$18.5M Sell
160,212
-3,142
-2% -$344K 3.29% 8
2018
Q2 		$16.9M Sell
163,354
-8,627
-5% -$873K 3.29% 10
2018
Q1 		$16.9M Sell
171,981
-40,054
-19% -$3.79M 2.98% 11
2017
Q4 		$18M Buy
212,035
+8,340
+4% +$689K 3.07% 9
2017
Q3 		$15.7M Sell
203,695
-9,136
-4% -$699K 3.09% 9
2017
Q2 		$16.6M Sell
212,831
-18,126
-8% -$1.3M 3.4% 8
2017
Q1 		$16.6M Sell
230,957
-1,767
-0.8% -$122K 3.52% 6
2016
Q4 		$14.4M Sell
232,724
-760
-0.3% -$46.5K 3.22% 8
2016
Q3 		$15.1M Sell
233,484
-29,574
-11% -$1.97M 3.28% 7
2016
Q2 		$16.6M Buy
263,058
+55
+0% +$3.24K 3.7% 3
2016
Q1 		$15.2M Sell
263,003
-205
-0.1% -$11.6K 3.42% 5
2015
Q4 		$14.1M Sell
263,208
-697
-0.3% -$39.3K 3.27% 7
2015
Q3 		$13.4M Buy
263,905
+4,257
+2% +$229K 3.16% 7
2015
Q2 		$14.6M Sell
259,648
-10,950
-4% -$691K 3.27% 7
2015
Q1 		$19.4M Sell
270,598
-32,760
-11% -$2.13M 4.24% 4
2014
Q4 		$17M Sell
303,358
-9,120
-3% -$476K 3.74% 6
2014
Q3 		$15.4M Sell
312,478
-22,814
-7% -$1.16M 3.46% 5
2014
Q2 		$17M Sell
335,292
-1,919
-0.6% -$95.1K 3.74% 4
2014
Q1 		$15.1M Sell
337,211
-3,460
-1% -$155K 3.42% 8
2013
Q4 		$16M Sell
340,671
-16,938
-5% -$857K 3.65% 7
2013
Q3 		$18.9M Buy
357,609
+566
+0.2% +$27.5K 4.59% 2
2013
Q2 		$16.1M Buy
+357,043
New +$16.9M 4.14% 2

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Halsey Associates's RMD Position: Q3 2019 in Review

Halsey Associates increased its ResMed (RMD) stake by 3.4% in Q3 2019, buying an estimated $709K and bringing the position to 165,966 shares worth $22.4M. The position accounts for 3.56% of the portfolio, ranked #7.

Halsey Associates first reported a position in RMD in Q2 2013 and has held it in 26 quarters since. 527 funds tracked by Wall St. Rank hold RMD as of Q3 2019.

  • Halsey Associates held 165,966 shares of ResMed worth $22.4M as of Q3 2019.
  • Halsey Associates bought 5,413 ResMed shares in Q3 2019, an estimated $709K.
  • ResMed made up 3.56% of Halsey Associates's portfolio in Q3 2019, its #7 holding.
  • Halsey Associates first reported a position in ResMed in Q2 2013 and has held it in 26 quarters since.
  • 527 funds tracked by Wall St. Rank held ResMed as of Q3 2019.

Based on Halsey Associates's 13F filing for Q3 2019, filed 15 Nov 2019.